Apyx Medical (NASDAQ:APYX) Rating Reiterated by JMP Securities

Apyx Medical (NASDAQ:APYX)‘s stock had its “market perform” rating reaffirmed by equities research analysts at JMP Securities in a research report issued on Monday, Benzinga reports.

Apyx Medical Stock Up 1.7 %

APYX stock traded up $0.02 during mid-day trading on Monday, hitting $1.18. 10,040 shares of the company were exchanged, compared to its average volume of 89,550. The firm has a market cap of $40.88 million, a P/E ratio of -1.79 and a beta of 1.20. Apyx Medical has a 1-year low of $0.97 and a 1-year high of $4.00. The company has a debt-to-equity ratio of 2.26, a quick ratio of 4.45 and a current ratio of 5.33. The firm’s 50 day simple moving average is $1.28 and its 200 day simple moving average is $1.45.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The company had revenue of $12.15 million for the quarter, compared to analyst estimates of $12.67 million. Apyx Medical had a negative return on equity of 105.45% and a negative net margin of 57.86%. During the same quarter in the previous year, the business earned ($0.11) earnings per share. On average, sell-side analysts predict that Apyx Medical will post -0.69 EPS for the current fiscal year.

Institutional Investors Weigh In On Apyx Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of APYX. Kingsview Wealth Management LLC acquired a new stake in shares of Apyx Medical in the fourth quarter valued at approximately $32,000. Worth Venture Partners LLC boosted its stake in shares of Apyx Medical by 12.0% during the 4th quarter. Worth Venture Partners LLC now owns 518,198 shares of the company’s stock worth $1,358,000 after buying an additional 55,592 shares during the last quarter. ProVise Management Group LLC bought a new position in shares of Apyx Medical in the 4th quarter valued at about $35,000. AIGH Capital Management LLC increased its position in shares of Apyx Medical by 7.7% in the fourth quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock valued at $5,346,000 after acquiring an additional 145,309 shares during the last quarter. Finally, Silverberg Bernstein Capital Management LLC raised its holdings in Apyx Medical by 1.2% during the first quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock worth $845,000 after acquiring an additional 7,507 shares in the last quarter. Institutional investors and hedge funds own 55.33% of the company’s stock.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.